Translate
Translate this website into the following languages:



Close Tab
Donations
UC San Diego Health
menu iconMenu
search iconSearch

Nationally Noted UC San Diego Allergist Elected ABAI President, 2010

 

September 02, 2008  |  

Stephen I. Wasserman, M.D., to Serve as President-Elect

The American Board of Allergy and Immunology (ABAI) announced that it has elected Stephen I. Wasserman, M.D., professor of medicine, UC San Diego School of Medicine and Director, Allergy/Immunology section, as the organization’s president-elect.  Dr. Wasserman will assume his duties as President on January, 1, 2010. 

ABAI is the entity that oversees the certification of physicians specializing in Allergy and Immunology.

As a teacher, researcher and physician, Wasserman has devoted more than 30 years of his career to the specialty of allergy and immunology.  Wasserman has worked at the University of California, San Diego since 1979, where he founded the Allergy and Immunology training program within the Department of Medicine.  From 2000 to the present, he has been listed in America’s “Top Doctors.”  Wasserman has received numerous grants for asthma research, in addition to writing and co-writing over 200 articles and book chapters.

Wasserman is also a featured doctor on the ABCNews.com “OnCallPlus” special section on asthma.  He answered various questions regarding topics such as the standard treatment of asthma, steroid use in controlling asthma, and the latest research being conducted at UC San Diego School of Medicine. 

Wasserman is a member of several professional societies including ABAI where he served as Chairman, the American Academy of Allergy, Asthma, and Immunology, where he served as president from 1998 – 1999, and the American Board of Medical Specialties, where he currently serves as Secretary/ Treasurer.  He is also certified by the American Board of Allergy and Immunology where he was elected as a Director, Secretary, Examination co-chair and served as Chairman. 

# # #

Media Contact: Kim Edwards, 619-543-6163, kedwards@ucsd.edu




Media Contact

Share This Article


Related News

12/1/2016
Previous studies identified the Hippo pathway kinases LATS1/2 as a tumor suppressor, but new research led by University of California San Diego School of Medicine scientists reveals a surprising role ...
11/30/2016
On November 4, 2016, surgeons at UC San Diego Health performed the region’s first combined heart-liver transplant (CHLT). During the 10-hour surgery, 54-year old Frank “Sonny” Taitano received a healt ...
11/22/2016
Genetic variations that increase schizophrenia risk are rare, making it difficult to study their role. To overcome this, the Psychiatric Genomics Consortium, an international team led by Jonathan Seba ...
11/21/2016
Researchers at University of California San Diego School of Medicine have identified a previously unknown mechanism that helps fortify the structure and tight junctions between epithelial cells — a ba ...



Follow Us

Our bimonthly newsletter delivers healthy lifestyle tips, patient stories and research discovery news. Subscribe: